Publication: Generation of pluripotent stem cells from patients with type 1 diabetes
Date
2009
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Proceedings of the National Academy of Sciences
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Maehr, René, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R. L. Leibel, and Douglas A. Melton. 2009. Generation of pluripotent stem cells from patients with type 1 diabetes. Proceedings of the National Academy of Sciences 106(37): 15768-15773.
Research Data
Abstract
Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic β cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.
Description
Other Available Sources
Keywords
β cell, disease model, autoimmune, directed differentiation, endoderm
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service